Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
or

Recursion Pharmaceuticals Inc Cl A (RXRX)

Recursion Pharmaceuticals Inc Cl A (RXRX)
10.98 x 10 11.00 x 13
Post-market by (Cboe BZX)
10.53 +2.03 (+23.88%) 02/14/25 [NASDAQ]
10.98 x 10 11.00 x 13
Post-market 11.00 +0.47 (+4.46%) 19:59 ET
Quote Overview for Fri, Feb 14th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
9.04
Day High
10.76
Open 9.17
Previous Close 8.50 8.50
Volume 83,547,102 83,547,102
Avg Vol 26,253,904 26,253,904
Stochastic %K 96.88% 96.88%
Weighted Alpha -20.83 -20.83
5-Day Change +3.04 (+40.59%) +3.04 (+40.59%)
52-Week Range 5.60 - 15.74 5.60 - 15.74
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,114,303
  • Shares Outstanding, K 390,722
  • Annual Sales, $ 44,580 K
  • Annual Income, $ -328,070 K
  • EBIT $ -394 M
  • EBITDA $ -370 M
  • 60-Month Beta 0.86
  • Price/Sales 40.04
  • Price/Cash Flow N/A
  • Price/Book 4.64

Options Overview Details

View History
  • Implied Volatility 128.11% ( +29.15%)
  • Historical Volatility 95.69%
  • IV Percentile 94%
  • IV Rank 43.53%
  • IV High 206.11% on 11/29/24
  • IV Low 67.98% on 09/24/24
  • Put/Call Vol Ratio 0.33
  • Today's Volume 133,581
  • Volume Avg (30-Day) 34,063
  • Put/Call OI Ratio 0.34
  • Today's Open Interest 249,364
  • Open Int (30-Day) 219,000

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.36
  • Number of Estimates 3
  • High Estimate -0.29
  • Low Estimate -0.42
  • Prior Year -0.40
  • Growth Rate Est. (year over year) +10.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.33 +66.35%
on 01/16/25
Period Open: 6.32
10.76 -2.09%
on 02/14/25
+4.21 (+66.61%)
since 01/14/25
3-Month
5.60 +88.04%
on 11/22/24
Period Open: 6.91
10.76 -2.09%
on 02/14/25
+3.62 (+52.39%)
since 11/14/24
52-Week
5.60 +88.04%
on 11/22/24
Period Open: 10.92
15.74 -33.10%
on 02/27/24
-0.39 (-3.57%)
since 02/14/24

Most Recent Stories

More News
Why Recursion Pharmaceuticals Stock Is Soaring Today

Shares of Recursion Pharmaceuticals (NASDAQ: RXRX) had soared by 15.8% as of 12:06 p.m. ET on Friday. Did the clinical-stage biotech company report great news? Nope. Instead, the stock's gains appeared...

NVDA : 138.85 (+2.63%)
RXRX : 10.53 (+23.88%)
Nvidia Invests in These 2 Artificial Intelligence (AI) Stocks and Sells These 3 Others

Nvidia's 13F revealed some interesting choices.

SERV : 13.85 (-39.57%)
NVDA : 138.85 (+2.63%)
SOUN : 10.97 (-28.10%)
WRD : 31.50 (+83.46%)
NBIS : 44.49 (+6.69%)
RXRX : 10.53 (+23.88%)
ARM : 159.54 (-3.21%)
Why SoundHound AI and Serve Robotics Stock Crashed on Friday

Nvidia announced it had sold shares of the popular AI stocks.

SERV : 13.85 (-39.57%)
NVDA : 138.85 (+2.63%)
SOUN : 10.97 (-28.10%)
WRD : 31.50 (+83.46%)
APLD : 9.11 (+15.17%)
RXRX : 10.53 (+23.88%)
ARM : 159.54 (-3.21%)
Biotechs on the Brink: 2 Stocks With Huge Potential

BriaCell Therapeutics and Recursion Pharmaceuticals are two biotech firms that may be poised for success in 2025; risk-tolerant investors might keep an eye out.

DRUG : 41.80 (-8.57%)
BCTX : 4.35 (+13.58%)
RXRX : 10.53 (+23.88%)
Recursion Presents Phase 2 Data for REC-994 in CCM in Late-Breaking Oral Presentation at the International Stroke Conference

RXRX : 10.53 (+23.88%)
3 Monster Stocks to Hold for the Next 10 Years

A handful of companies are in the right place at the right time with the right product or service.

NFLX : 1,058.60 (+1.43%)
ROKU : 99.07 (+14.14%)
AAPL : 244.60 (+1.27%)
CMCSA : 35.39 (+0.03%)
PARA : 11.30 (+4.53%)
WBD : 10.34 (+1.32%)
RKLB : 28.02 (-0.99%)
RXRX : 10.53 (+23.88%)
AMZN : 228.68 (-0.73%)
DIS : 110.38 (+0.72%)
AI Pharma: 2 Paths to AI-Powered Drug Investment

AI is transforming drug development, allowing companies to identify new drug targets, optimize clinical trials and speed delivery of medicines to patients.

LLY : 844.27 (-3.00%)
GPCR : 24.39 (+0.08%)
SDGR : 24.85 (+1.72%)
NVS : 105.43 (-2.12%)
RXRX : 10.53 (+23.88%)
Nvidia-Backed Recursion Pharma Hits 3-Week High, Sparks Retail Buzz Amid Broader AI Hype

The AI chipmaker’s $50 million investment in Recursion, unveiled in 2023 to support AI-driven drug discovery, has been a key driver of investor interest.

NVDA : 138.85 (+2.63%)
RXRX : 10.53 (+23.88%)
2 Growth Stocks That Could Rocket Higher in the First Quarter of 2025

Investors looking for stocks that could make dramatic moves in a short, defined time frame will want to turn their attention toward two innovative drugmakers. A couple of stocks in the volatile biopharmaceutical...

NVDA : 138.85 (+2.63%)
ARVN : 18.31 (+3.62%)
RXRX : 10.53 (+23.88%)
Healthcare AI Adoption Accelerates as Industry Eyes $125 Billion Growth by 2028

/CNW/ -- According to experts, soon the integration of artificial intelligence (AI) into healthcare will drastically shift from a novelty, to a critical...

AVAI : 0.6100 (-3.17%)
TDOC : 14.33 (+6.07%)
ABSI : 5.82 (+16.40%)
RXRX : 10.53 (+23.88%)
BFLY : 4.77 (+2.58%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strongest short term outlook on maintaining the current direction.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Recursion Pharmaceuticals Inc. is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science and engineering. Recursion Pharmaceuticals Inc. is based in SALT LAKE CITY.

See More

Key Turning Points

3rd Resistance Point 12.89
2nd Resistance Point 11.82
1st Resistance Point 11.18
Last Price 10.53
1st Support Level 9.46
2nd Support Level 8.39
3rd Support Level 7.75

See More

52-Week High 15.74
Fibonacci 61.8% 11.87
Fibonacci 50% 10.67
Last Price 10.53
Fibonacci 38.2% 9.47
52-Week Low 5.60

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Increase Profitable Opportunities with Barchart's Technical Opinion